Quest
Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment
Agilent's companion diagnostic for Mirati's non-small cell lung cancer treatment Krazati will be available through Quest's national healthcare network.
In Brief This Week: 908 Devices, Natera, PerkinElmer, Hologic, Hamilton, BioFluidiX, More
News items for the week of Nov. 14, 2022
At the AMIA annual symposium, stakeholders discussed barriers to pharmacogenomics adoption and pitfalls in delivering the right information to the right place at the right time.
In Brief This Week: Pacific Biosciences, Pierian, PerkinElmer, Ginkgo Bioworks, More
News items for the week of Oct. 17, 2022.
The firm alleges its competitors infringe its patents describing processes for finding chromosomal abnormalities in fetal cell-free DNA.
Dec 20, 2020